UiPath ve 2. čtvrtletí zvýšil tržby o 13,4 % na 410,3 mil. USD a poprvé po čtyřech kvartálech vykázal GAAP zisk. Akcie PATH přesto od zveřejnění výsledků klesly o 24 %.
Key Takeaways UiPath shares fell 24% despite Q2 revenues beating expectations and full-year guidance being raised.PATH's ARR rose 12.5% year over year, while AI featured in 18 of the quarter's 20 largest deals.UiPath posted a fourth straight GAAP-profitable quarter and ended Q2 with $1.405 billion in cash. UiPath’s (PATH - Free Report) latest results merit another look after the market has had time to digest them. Shares have fallen 24% since the Sept. 3 release, even though second-quarter fiscal 2027 revenues exceeded expectations and management lifted its annual targets.
The reaction appears less about the reported quarter than the outlook’s magnitude and composition: the fiscal third-quarter revenue midpoint sits below the consensus mark, while the modest ARR-guidance increase leaves investors waiting for clearer AI-driven acceleration. That reset, however, creates a more interesting entry point, provided execution continues.
Image Source: Zacks Investment Research
PATH’s YoY Revenue Growth Beats ExpectationsFiscal second-quarter revenues rose 13.4% year over year to $410.3 million, beating the $397.8 million consensus mark by 3.1%. Revenues nevertheless have declined 1.9% sequentially from $418.4 million. License revenues increased 10.4% year over year to $123.8 million but fell 17.1% from the fiscal first quarter.
Subscription-services revenues advanced 11.6% year over year and 5.2% sequentially to $266.1 million, improving the recurring-revenue mix. Professional services and other revenues surged 81.6% year over year and 25.8% quarter over quarter to $20.3 million, although they remained a small contributor.
PATH’s Margin Expansion Confirms Better Operating DisciplineGAAP gross profit increased 10.9% year over year but declined 3.5% sequentially to $329.7 million. The corresponding gross margin was 80%, down two percentage points both year over year and sequentially. Non-GAAP gross margin similarly contracted to 82% from 84% a year ago and 83% in the prior quarter.
Lower operating expenses offset that pressure. GAAP operating income reached $31.6 million, reversing a $20.2 million loss a year earlier and rising 12.9% sequentially. Operating margin improved to 8% from negative 6% and 7% in the prior year and prior quarter, respectively. This marked UiPath’s fourth consecutive quarter of GAAP profitability.
Non-GAAP operating income climbed 42.9% year over year to $89 million, though it slipped 3.7% sequentially. Its 22% margin expanded five percentage points year over year and held steady quarter over quarter. Adjusted earnings were 15 cents per share, unchanged both year over year and sequentially.
ARR Gains Support the AI Thesis, but Acceleration Is Still NeededARR reached $1.938 billion, up 12.5% year over year and 1.9% sequentially. Net new ARR was $37 million, 19.4% above the prior-year quarter but 24.5% below the first quarter’s $49 million. Dollar-based net retention was 109%, improving one percentage point year over year and remaining flat sequentially. Gross retention held at 97%, with attrition concentrated among smaller customers.
Image Source: Zacks Investment Research
AI appeared in 18 of the quarter’s 20 largest deals, suggesting it is becoming central to enterprise purchases. UiPath’s proposition combines probabilistic AI with rules-based automation, while model neutrality and integrations with major coding assistants broaden its relevance. Larger outcome-oriented contracts could lift deal sizes, but evolving transaction-based pricing makes near-term monetization less predictable.
Raised Guidance Is Positive, Yet the Upside Looks MeasuredFiscal third-quarter revenue guidance of $440-$445 million has a $442.5 million midpoint, lower than the $444.3 million Zacks Consensus Estimate. ARR is projected at $1.992-$1.997 billion, implying 2.9% sequential growth at the midpoint, while non-GAAP operating income of roughly $100 million suggests a margin near 22.6%.
Full-year revenue guidance increased to $1.789-$1.794 billion from $1.776-$1.781 billion, representing a 0.7% midpoint raise and higher than the current Zacks Consensus Estimate of $1.78 billion. The ARR range moved up just 0.3% at the midpoint to $2.065-$2.070 billion, while non-GAAP operating-income guidance rose 3.5% to $445 million. Adjusted free cash flow is expected to approximate $425 million. The sharper profit revision is encouraging, but the restrained ARR increase helps explain why the market focused on competitive AI risk rather than the headline beat.
ServiceNow and Salesforce Set a Demanding Competitive BarServiceNow (NOW - Free Report) and Salesforce (CRM - Free Report) provide useful benchmarks for UiPath’s AI-automation opportunity. ServiceNow embeds AI agents and workflow orchestration across its enterprise platform, giving it a large installed-base advantage and substantial cross-selling reach. Salesforce similarly connects autonomous agents with customer data, applications and workflows through Agentforce, making it a formidable competitor for enterprise automation budgets.
Yet UiPath retains differentiation in deterministic robotic automation, model neutrality and governance across mixed human, software and agent processes. ServiceNow may appeal to customers standardizing IT workflows, while Salesforce is strongest around customer-facing processes. UiPath’s opportunity lies in serving as the controlled execution layer across both domains, especially for complex, regulated operations over the coming investment cycle.
Cash Generation Moderated, but the Balance Sheet Remains StrongOperating cash flow fell 26.2% year over year and 76.7% sequentially to $30.7 million. Adjusted free cash flow was about $31 million, down 31.1% year over year and 76.2% sequentially, reflecting quarterly timing following a strong first quarter.
UiPath still ended the period with $1.405 billion in cash and investments, down only 1.1% sequentially, and no debt. It also repurchased 2.4 million shares at an average price of $9.63, providing modest support while preserving substantial financial flexibility.
Verdict: The Selloff Makes PATH a BuyThe post-earnings decline has created an attractive entry point for investors willing to tolerate volatility. UiPath is pairing durable recurring-revenue growth with stronger retention, disciplined spending and sustained profitability, while its debt-free balance sheet provides room to keep investing. The market’s concern that general-purpose AI tools could erode traditional automation demand is legitimate, and near-term growth remains measured. However, enterprises still require accuracy, governance and orchestration when automated decisions reach core operations. UiPath’s model-neutral platform is designed for precisely that need. With execution improving and expectations reset after the selloff, the risk-reward balance supports a Buy for patient investors today.
PATH stock currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
UiPath po silných výsledcích klesá o 7 %, přestože Wall Street zvýšila cílové ceny; žádný analytik ale nepřešel na nákupní doporučení. Pegasystems ve stejném sektoru také odepsal 7 %.
Wall Street just raised price targets on UiPath across the board after a strong earnings beat, yet not a single analyst upgraded the stock. Here is why four simultaneous target hikes are actually a bearish signal for automation software investors.
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
The enterprise AI automation cohort is selling off Tuesday as Wall Street’s response to UiPath‘s (NYSE:PATH | PATH Price Prediction) fiscal second-quarter report crystallizes into a chorus of higher price targets paired with non-buy ratings. The iShares Expanded Tech-Software Sector ETF (CBOE:IGV) is down 2% on the session, and the automation names inside it are pacing the decline. Analysts think UiPath stock is worth more than it was a week ago, but their ratings remain firmly on the sidelines.
UiPath stock is down 7% to $14.11 in Tuesday afternoon trading, extending a selloff that has undone a 40% August rally into earnings. Pegasystems (NASDAQ:PEGA) shares are down 7% to $34.86 without a fresh company-specific catalyst, seemingly moving in sympathy with the group.
Meanwhile, C3.ai (NYSE:AI) stock is down 1% to $10.35, holding up notably better than its peers. That relative resilience complicates any read that the entire agentic AI software group is being marked down as one block, because C3.ai’s own turnaround narrative from last week’s earnings call gives it a different setup from UiPath’s growth-quality debate.
Four Target Hikes, Zero Buy Ratings UiPath’s fiscal Q2 2027 revenue of $410.26 million topped estimates, and annual recurring revenue reached $1.938 billion, up 12% year over year. The company also swung to $32 million in GAAP operating income from a prior-year loss, marking its fourth consecutive quarter of GAAP profitability. That combination was enough for four Wall Street firms to lift price targets while leaving all of them parked on the sidelines.
Koji Ikeda at Bank of America raised his PATH stock price target to $15 while keeping an Underperform rating, arguing the quarter did little to answer whether AI will meaningfully accelerate ARR growth. Truist lifted its target to $17 with a Hold on more agentic AI deals and modest customer growth improvement, and TD Cowen went to $16 with a Hold, citing steady performance and stable retention. DA Davidson also nudged its target higher while keeping a Neutral rating, rounding out a group that collectively signaled the recent rally had gotten ahead of the fundamentals.
Pegasystems Caught in the Same Downdraft Pegasystems carries its own overhang from its Q2 2026 report, when total annual contract value (ACV) growth slowed to 7% year over year and CEO Alan Trefler flagged AI-driven client hesitation that management warned could persist through year-end. Pega Cloud remained a bright spot, with Pega Cloud ACV up 22% to $926.29 million, though the topline miss and elongated sales cycles left Pegasystems stock exposed to any negative read across the automation software peer group.
With no obvious news of its own today, the 7% PEGA stock drop looks like guilt by association with UiPath rather than a stand-alone Pegasystems catalyst. Pegasystems stock’s 41% year-to-date decline shows how much repair work is already priced in, which arguably raises the bar for meaningful further downside on sector sympathy alone.
What to Watch Next The next scheduled test for UiPath is its investor day in Las Vegas on September 22, followed by its Fusion user conference running through September 25. That’s the venue where management can put a sharper number on how AI attach rates translate into ARR acceleration, which is the specific bar every analyst note pointed to on Tuesday.
The bull case rests on AI-attached deals meaningfully widening deal scope and stickiness, and UiPath said 18 of its top 20 deals in the quarter included AI. The bear case is that four target hikes with no rating changes is Wall Street’s polite way of saying the fundamentals haven’t yet earned a rerating, particularly with UiPath stock having rallied hard into the report.
Shareholders can watch for a lifted ARR outlook at UiPath’s investor day, or another quarter of the growth question being deferred. Position sizing on both UiPath and Pegasystems should stay modest given the recent volatility, and investors holding either name should keep their exposure trimmed to survive a stretch of range-bound trading if the automation-software rotation drags on.
Contact [email protected] for any questions or corrections.
UiPath ve fiskálním 2. čtvrtletí zvýšil tržby o 13 % na 410 milionů USD a celoroční výhled tržeb zvedl na 1,789–1,794 miliardy USD. Akcie přesto klesly o 16,63 %.
Shares of UiPath (PATH -16.63%) sank despite the company reporting solid fiscal second-quarter results and raising its full-year guidance. The stock is now down on the year, as of this writing.
UiPath began as a robotic process automation (RPA) company that lets customers use software bots to perform repetitive, rule-based tasks; however, it has been in the middle of transforming itself in the age of artificial intelligence (AI). Its goal now is to be an orchestration platform that can combine AI with deterministic automation.
Let's dig into the company's quarterly results and prospects to see if this dip is a buying opportunity.
Premium Feature
Moneyball Superscore
73/100
Today's Change
(
-16.63
%) $
-3.03
Current Price
$
15.19
Moving in the right direction UiPath said its platform that can orchestrate both AI agents and bots was beginning to resonate with customers as it can give them better returns on their investments and that its strong roots in governance and reliability were a competitive advantage. It also believes that being AI model agnostic is an important differentiator. Its AI momentum could be seen in the quarter with 18 of its 20 largest deals including an AI component.
The company has been working to strengthen its go-to-market strategy and said increased deal sizes and expanded customer engagement were evidence this was starting to pay off. However, it noted that customer education was still important, as it looks to bestow the benefits of how combining AI with deterministic automation can help enterprises. The company is also considering offering outcome-based pricing models to increase customer value and adoption. Finally, it continues to add prebuilt vertical and outcome-oriented solutions to help drive growth and be a gateway for its entire solution.
For its fiscal Q2, revenue rose 13% year over year to $410 million, cruising past guidance for revenue of between $395 to $400 million. Its annualized recurring revenue (ARR) rose by 12% year over year to $1.94 billion. Meanwhile, it added $37 million in new ARR in the quarter, up 19% year over year. UiPath's ARR is made up of its annualized invoiced amounts from subscription licenses and maintenance and support obligations, while it excludes invoiced amounts related to perpetual licenses or professional services. The metric is similar to bookings.
Dollar-based net retention came in at 109%, showing that the company is seeing solid growth within its existing customer base. It also had 97% gross retention.
UIPath ended the quarter with 10,350 customers, which was down from 10,550 at the end of Q1 as it continues to see attrition among smaller customers. Customers with $30,000 or more in ARR increased by 6% year over year, and customers with $100,000 or more in ARR increased 10%. Meanwhile, customers with $1 million or more in ARR jumped 21% to 387.
Adjusted earnings per share (EPS) was steady at $0.15. The company generated $31 million in operating cash flow and free cash flow. It ended the quarter with $1.41 billion in cash and marketable securities and no debt.
Looking ahead, UIPath forecast Q3 revenue in the range of $440 million to $445 million, representing growth of 8% at the midpoint. It guided for ARR between $1.992 billion and $1.997 billion.
For the full year, it raised its revenue guidance to a range of $1.789 billion to $1.794 billion from an earlier outlook of $1.776 billion to $1.781 billion. It now expects ARR of $2.065 billion to $2.070 billion versus between $2.058 billion and $2.063 billion previously.
Image source: The Motley Fool
Can the stock rebound? UiPath continues to have a nice opportunity in front of it, and it appears to be seeing some green shoots from its efforts. However, for the stock to work, it does really need to see growth start to accelerate.
The stock remains relatively cheap, trading at a forward price-to-sales ratio of 4.4 times for a high gross margin, recurring business model. Take out its $1.4 billion in cash and marketable securities, and the stock trades at an enterprise-value -to-forward-sales ratio of just around 3.5.
Given its valuation, I think UiPath remains an interesting, speculative AI stock to own.
AXQ Capital LP acquired a new stake in UiPath, Inc. (NYSE:PATH – Free Report) during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 159,705 shares of the company’s stock, valued at approximately $1,736,000.
Several other large investors have also recently added to or reduced their stakes in PATH. HighMark Wealth Management LLC acquired a new stake in UiPath in the fourth quarter valued at about $25,000. Trifecta Capital Advisors LLC acquired a new stake in shares of UiPath in the second quarter valued at about $27,000. Atlas Capital Advisors Inc. purchased a new position in UiPath in the 4th quarter valued at approximately $37,000. AdvisorNet Financial Inc increased its position in shares of UiPath by 750.0% in the first quarter. AdvisorNet Financial Inc now owns 3,400 shares of the company’s stock valued at $38,000 after buying an additional 3,000 shares in the last quarter. Finally, REAP Financial Group LLC acquired a new position in UiPath during the fourth quarter worth about $44,000. 62.50% of the stock is owned by hedge funds and other institutional investors.
Trending Headlines about UiPath Here are the key news stories impacting UiPath this week:
Positive Sentiment: UiPath reported fiscal Q2 revenue of approximately $410.3 million, up about 13% year over year and above the $397.8 million analyst estimate. Adjusted EPS of $0.15 matched expectations, while the company posted its fourth consecutive quarter of GAAP profitability. UiPath Reports Second Quarter Fiscal 2027 Financial Results Positive Sentiment: Annual recurring revenue rose 12% to $1.938 billion. Management said AI-led orchestration is helping generate larger strategic deals, broaden platform adoption and improve retention, supporting its view that AI can expand demand for automation. PATH Q2 Earnings Call Centers on AI-Led Platform Expansion Positive Sentiment: Several firms raised their price targets after the report, including BMO Capital Markets to $18 and Truist Financial to $17, reflecting improved valuation support despite generally cautious ratings. Neutral Sentiment: UiPath lifted its fiscal 2027 revenue outlook to approximately $1.789 billion-$1.794 billion and guided fiscal Q3 revenue to $440 million-$445 million, broadly in line with expectations. The outlook represents an improvement but does not signal a sharp reacceleration. UiPath Fiscal 2027 Guidance Neutral Sentiment: The company announced executive leadership changes and appointed a new board member, adding a transition element for investors to monitor. UiPath Announces Executive Leadership Changes Negative Sentiment: Investors viewed the guidance as evidence that growth may remain near 12%-13%, with limited proof of sustained acceleration. That concern overshadowed the quarterly revenue beat, particularly after the stock’s recent rally. UiPath Tumbles as Guided Slowdown Overshadows Revenue Beat Negative Sentiment: Competition and disruption concerns persist as investors question whether generative AI and rival platforms could pressure UiPath’s automation business. Analyst reactions remained restrained: Mizuho, Wells Fargo and Bank of America retained neutral-to-negative stances despite raising targets. UiPath Slips as Competition Concerns Persist UiPath Stock Performance PATH stock opened at $15.27 on Friday. UiPath, Inc. has a 1 year low of $9.20 and a 1 year high of $19.84. The stock has a market capitalization of $7.91 billion, a price-to-earnings ratio of 22.79, a PEG ratio of 2.18 and a beta of 1.02. The stock’s fifty day moving average is $13.92 and its two-hundred day moving average is $11.94. UiPath (NYSE:PATH – Get Free Report) last released its quarterly earnings results on Thursday, September 3rd. The company reported $0.15 EPS for the quarter, hitting the consensus estimate of $0.15. UiPath had a net margin of 21.03% and a return on equity of 9.68%. The business had revenue of $410.26 million during the quarter, compared to analyst estimates of $397.77 million. During the same quarter in the prior year, the firm earned $0.15 earnings per share. The company’s quarterly revenue was up 13.3% on a year-over-year basis. As a group, analysts predict that UiPath, Inc. will post 0.4 EPS for the current fiscal year.
Analyst Ratings Changes A number of research firms recently commented on PATH. Wells Fargo & Company increased their price objective on UiPath from $13.00 to $15.00 and gave the company an “equal weight” rating in a research note on Friday. Oppenheimer reaffirmed a “market perform” rating on shares of UiPath in a research note on Friday. TD Cowen raised their price objective on UiPath from $13.00 to $16.00 and gave the company a “hold” rating in a research report on Friday. Mizuho lifted their price target on shares of UiPath from $12.00 to $14.00 and gave the stock a “neutral” rating in a research note on Friday. Finally, Royal Bank Of Canada raised their price objective on UiPath from $15.00 to $17.00 and gave the company a “sector perform” rating in a research note on Friday. Two investment analysts have rated the stock with a Buy rating, sixteen have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $16.33.
View Our Latest Stock Analysis on UiPath
Insider Buying and Selling In other UiPath news, CEO Daniel Dines sold 1,402,347 shares of the firm’s stock in a transaction that occurred on Wednesday, August 19th. The shares were sold at an average price of $16.07, for a total value of $22,535,716.29. Following the sale, the chief executive officer owned 26,491,238 shares in the company, valued at approximately $425,714,194.66. This trade represents a 5.03% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Company insiders own 22.44% of the company’s stock.
UiPath Profile (Free Report)
UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization. Its platform's embedded AI, ML, and NLP capabilities improve decisioning and information processing; emulate human behavior allows organizations to address a myriad of use cases; emulate human behavior allows organizations to address a myriad of use cases; multi-tenant platform enterprise deployment with security and governance and Automation Cloud, which enables customers to begin automating without the need to provision infrastructure, install applications, or perform additional configurations; intuitive interface and low-code, drag-and-drop functionality; signed to enable people and automations to work together; and tracks, measures, and forecasts the performance of automations, enables customers to gain powerful insights and generate key performance indicators with actionable metric.
Featured Stories Five stocks we like better than UiPath Revolution Medicines Got Its Breakthrough—What Moves It Next? Retail Earnings Just Exposed a Bigger Divide in the U.S. Consumer Economy FB Financial’s Southern Expansion and Buybacks Drive Analyst Optimism AST SpaceMobile Stock Soared 12%—This Was the Catalyst Want to see what other hedge funds are holding PATH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UiPath, Inc. (NYSE:PATH – Free Report).
Receive News & Ratings for UiPath Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UiPath and related companies with MarketBeat.com's FREE daily email newsletter.
UiPath po výsledcích za 2. čtvrtletí zvýšil výhled tržeb pro fiskální rok 2027 na 1,789–1,794 miliardy USD. Akcie v pátek klesly o 12,4 % na 15,98 USD.
UiPath Inc (NYSE:PATH) reported mixed results for the second quarter and raised its FY27 sales guidance on Thursday.
UiPath reported quarterly earnings of 15 cents per share, in line with the consensus estimate, per Benzinga Pro data. Quarterly revenue came in at $410.26 million, which beat the Street estimate of $397.95 million.
"I am pleased with our second quarter results, demonstrating disciplined execution and the growing momentum across our platform," said Daniel Dines, UiPath founder and CEO.
UiPath raised its fiscal 2027 revenue outlook to between $1.789 billion and $1.794 billion, versus the $1.778 billion analyst estimate.
UiPath shares fell 12.4% to trade at $15.98 on Friday.
These analysts made changes to their price targets on UiPath following earnings announcement.
Canaccord Genuity analyst Kingsley Crane downgraded the stock from Buy to Hold and raised the price target from $15 to $17. DA Davidson analyst Lucky Schreiner maintained the stock with a Neutral and raised the price target from $12 to $16. Trending
Considering buying PATH stock? Here’s what analysts think:
Photo via Shutterstock
Market News and Data brought to you by Benzinga APIs
UiPath, Inc. (PATH) Q2 2027 Earnings Call September 3, 2026 5:00 PM EDT
Company Participants
Allise Furlani - Senior Director of Investor Relations
Daniel Dines - Co-Founder, CEO, & Executive Chairman of the Board
Ashim Gupta - CFO & COO
Hitesh Ramani - Deputy CFO & Chief Accounting Officer
Conference Call Participants
Sanjit Singh - Morgan Stanley, Research Division
Bryan Bergin - TD Cowen, Research Division
Scott Berg - Needham & Company, LLC, Research Division
Jacob Zerbib - William Blair & Company L.L.C., Research Division
Raimo Lenschow - Barclays Bank PLC, Research Division
Terrell Tillman - Truist Securities, Inc., Research Division
Sanika Merchant - RBC Capital Markets, Research Division
Presentation
Operator
Good day, everyone. My name is Megan, and I will be your conference operator today. At this time, I would like to welcome you to the UiPath Second Quarter 2027 Earnings Conference Call. [Operator Instructions] At this time, I would like to turn the call over to Allise Furlani, Vice President of Investor Relations.
Allise Furlani
Senior Director of Investor Relations
Good afternoon, and thank you for joining us today to review UiPath's second quarter fiscal 2027 financial results, which we announced in our earnings press release issued after the close of the market today. On the call with me are Daniel Dines, Founder and Chief Executive Officer; Ashim Gupta, Chief Operating Officer; and Hitesh Ramani, Chief Financial Officer, to deliver our prepared comments and answer questions. Our earnings press release and financial supplemental materials are posted on the UiPath Investor Relations website. These materials include GAAP to non-GAAP reconciliations. We will be discussing non-GAAP measures on today's call.
This afternoon's call includes forward-looking statements regarding our financial guidance for the third quarter and full fiscal year 2027, and our ability to drive and accelerate future growth and operational efficiency and grow our platform, product offerings and market
UiPath po výsledcích za 2. čtvrtletí vzrostl o 12 %, když výnosy 410,26 mil. USD překonaly odhad 397,85 mil. USD a upravený EPS byl v souladu s očekáváním.
Live 6 updates · Last at 4:55pm ET Updates appear automatically.
By Thomas Richmond · Updated Sep 3, 4:55pm ET · Published Sep 3, 3:27pm ET
Live UpdatesNewest first
That wraps up our initial coverage of UiPath’s Q2 results. Thank you for stopping by!
UiPath just reported earnings, with shares initially up 12% following the report. Here are the key numbers:
Revenue: $410.26M vs. $397.85M expected Adjusted EPS: $0.15 vs. $0.15 expected Quick Read:
UiPath beat revenue expectations by roughly 3% while adjusted EPS came in exactly in line with Wall Street estimates.
The 12% initial surge suggests investors like the top-line momentum, with revenue growing 13% year over year as Wall Street looks for evidence that UiPath’s agentic AI strategy is accelerating growth.
Bull Case: Momentum, Margins, and Agentic Traction Consistent revenue beats: , with Q1 revenue of . , and AI expansion deals ran six times larger. GAAP profitability arrived for the first time, with Q1 non-GAAP operating margin at . EPS revisions skew positive: . Bear Case: High Bar, Decelerating Growth Shares are up , raising the setup risk. ARR growth is stuck near , well below prior levels. Q1 EPS missed by , and analysts remain . Insider direction is , an odd counterpoint to the rally.
With UiPath (NYSE:PATH) reporting after the close, here is what to listen for on the call.
Top 5 Analyst Questions Is net new ARR reaccelerating above the posted in Q1? How much is agentic AI contributing, given already include it? Path to the long-term non-GAAP margin target? Competitive wins versus Microsoft Power Automate and Salesforce Agentforce? Pace of buybacks after repurchased in Q1? Key Topics and Buzzwords Maestro Case, UiPath for Coding Agents, WorkFusion contribution, outcome-based pricing. Listen for “orchestration,” “deterministic plus agentic,” “pilot to production.” Red Flags ARR at the low end of . DBNR slipping below . Any full-year guide trim versus the range, which would jeopardize the one-month rally.
Insider Activity Scorecard Date Insider Title Transaction Shares Price Sell Chief Accounting Officer Sell Hitesh Ramani Chief Accounting Officer Sell COO & CFO Sell 2026-07-01 CPO & CTO Sell $10.87 Insider activity at UiPath (NYSE:PATH) over the past 90 days skewed decisively toward selling.
CEO Daniel Dines’ disposal of over 1.4 million shares dwarfed every other filing. Chief Accounting Officer Hitesh Ramani added back-to-back sales in the mid-$16s. dispositions from Gupta, Malpani, and Legal Chief Brad Brubaker at $10.87 appear tied to vesting. The only acquisitions were , reflecting equity awards rather than open-market conviction. Dashboard data confirms net insider direction is .
With shares up in a month, executives leaned into strength rather than adding exposure ahead of tonight’s earnings report, a caution flag against the setup.
UiPath is expected to report fiscal Q2 2027 earnings at 4:10 PM ET, with Wall Street looking for evidence that its agentic AI push is translating into stronger recurring revenue growth.
Management has guided for revenue of $395-$400 million and ARR between roughly $1.929-$1.934 billion. Investors will also be watching net new ARR, with a figure above roughly $49 million providing another signal that growth is accelerating.
The stakes are high after UiPath shares soared around 40% over the past month. A higher full-year ARR outlook could validate the rally and strengthen the case that UiPath is evolving from a traditional automation vendor into a broader enterprise AI orchestration platform.
A guidance cut would tell a very different story and could put much of the stock’s recent rally at risk.
This article is updated throughout the trading day. Check back for more.
Full CoverageThe story so far
UiPath (NYSE:PATH | PATH Price Prediction) is expected to report Q2 FY2027 results after the bell at 4:10 PM ET. Shares enter the report tonight at about $18.52, up around 65.05% over the past year on rising evidence that agentic AI is moving from pilot to production.
Momentum Meets a Higher Bar Q1 FY27 delivered revenue of $418.38M, up 17.3% YoY, beating consensus by 5.26%, while adjusted EPS of $0.15 came in 5.48% shy of estimates. ARR grew 12% YoY to $1.901B on $49M of net new ARR, and dollar-based net retention ticked up to 109% from 107%.
Non-GAAP operating margin expanded to 22% from 20%, and stock-based compensation dropped to $53.3M from $76.4M. Management raised the FY27 non-GAAP operating income target to ~$430M and repurchased $243.8M of Class A stock. With PATH up over 40% in the past month, the setup rewards execution and punishes any ARR softness.
Consensus Estimates Metric Q2 FY27 Estimate YoY Change FY2027 Estimate FY2028 Estimate Revenue $397.85M +14.5% $1.778B $1.928B EPS (Normalized) $0.1474 +76.7% $0.7828 $0.9066 FY27 revenue growth is modeled near 10.4%, a step down from FY26’s 12.65%. FY28 revenue growth of 8.4% pairs with EPS growth of 15.8%, consistent with continued margin leverage. The Q2 EPS consensus has held flat at $0.1474 across the last 60 days, with 10 upward revisions in the past week.
What I’m Watching Tonight: ARR, Margins, and Agentic AI Tonight, I’ll be watching the ARR results against the $1.929B-$1.934B guide. Net new ARR needs to hold or exceed $49M to keep the stabilization-to-reacceleration thesis intact. On revenue mix, 16 of the top 20 Q1 deals included AI, and AI-inclusive expansions ran six times larger than those without. It would be great to see that continue to expand.
Analysts will also focus on dollar-based net retention. It moved 108% to 107% to 107% to 109% across the last four quarters. A result above 109% validates the reacceleration narrative CEO Daniel Dines flagged on the last call.
Non-GAAP operating margin was 22% in Q1 and 31% in Q4 FY26. Guidance implies compression this quarter, so investors will focus on whether spend on coding agents, Test Cloud, and forward-deployed engineering is moving progress toward the 30% long-term target.
Also on the list: traction for UiPath for Coding Agents, the Deloitte Agentic ERP alliance, and Maestro Case orchestration momentum. Guidance credibility is the tiebreaker after Q4 FY26’s cautious FY27 outlook sent shares -8.16% the next day.
Earnings History Quarter EPS Surprise 1-Day Move 7-Day Move 30-Day Move Q1 FY27 -5.48% +1.21% +0.78% -6.13% Q4 FY26 +17.74% -8.16% +0.57% -18.26% Q3 FY26 +9.59% +24.36% +25.77% +16.62% Q2 FY26 +79.86% +5.90% +7.74% +33.82% On average, shares moved 8.88% seven days after earnings over the past year.
Contact [email protected] for any questions or corrections.
Thomas Richmond
Thomas Richmond is a financial writer and content strategist with 5+ years of experience covering stocks and financial markets. He has published over 250 articles focused on individual stock analysis, helping investors better understand business fundamentals, stock valuations, and long-term opportunities.
Thomas previously served as a Content Lead at TIKR, a stock research platform, where he helped scale the company’s blog to hundreds of articles per month and contributed to a weekly newsletter reaching more than 100,000 investors.
He specializes in breaking down complex companies into clear, actionable insights for everyday investors, with a focus on fundamentals-driven research.
His work has also been featured on platforms including Seeking Alpha and Sure Dividend.
Outside of work, Thomas enjoys weight lifting and soccer.
AI software company UiPath Inc. (NYSE:PATH) looks to continue its strong stock momentum from the last month, with second-quarter financial results coming Thursday after market close.
Here are the earnings estimates, analyst ratings and key items to watch.
UiPath Q2 Earnings EstimatesAnalysts expect UiPath to report second-quarter revenue of $397.95 million, up from $362.00 million in last year’s second quarter, according to data from Benzinga Pro.
The company has beaten revenue estimates from analysts in five straight quarters and in nine of the last 10 quarters overall.
While the revenue estimate would mark a year-over-year gain, it comes after three straight quarters of revenue of $411 million or more.
Guidance from the company calls for second-quarter revenue to be in a range of $395 million to $400 million.
Analysts expect UiPath to report second-quarter earnings of 15 cents per share, in line with last year’s total of 15 cents per share in the second quarter.
The company missed analyst estimates for earnings per share in the first quarter, but has beaten estimates in nine of the last 10 quarters overall.
Read Next
UiPath Analyst Ratings and Price TargetsThere are not many analyst ratings on UiPath ahead of quarterly results. Here are the latest ratings and price targets:
UBS: Maintained Neutral rating, raised price target from $12 to $19 RBC Capital: Maintained Sector Perform rating, raised price target from $12 to $15 Key Items to WatchUiPath comes into the earnings report with shares up 36% over the last month. The recent gains top the year-to-date performance of 14.6%. UiPath stock is currently at its highest level since December 2025 and could be ready to set new 52-week highs with a strong report.
The first quarter saw mixed results, with the company missing earnings per share for the first time in more than 10 quarters. Revenue beat analyst estimates, continuing a strong streak of beats.
In the first quarter, UiPath reported annual recurring revenue of $1.901 billion, up 12% year-over-year. This will be a key figure to watch to see whether recurring revenue from customers continues to grow.
The company expects annual recurring revenue to be in a range of $1.929 billion to $1.934 billion in the second quarter.
Company management said agentic products are moving from pilot to production, which could set UiPath up for increased revenue opportunities going forward.
With shares ready to break out, analysts and investors will likely be looking for a double beat, strong guidance and an update on agentic products.
UiPath Stock Price ActionUiPath stock is down 2% to $17.76 on Wednesday versus a 52-week trading range of $9.20 to $19.84.
UiPath představil Maestro Flow, novou orchestrace pro vývojáře, která umožňuje z kódovacích agentů tvořit, spouštět a řídit celé firemní procesy bez přepisování. Platforma má propojit AI agenty, roboty, API, dokumenty i lidi v jednom toku.
New orchestration capability lets builders use any coding agent to build, run, and govern complete business processes—no rewrite required to ship
NEW YORK--(BUSINESS WIRE)--UiPath, Inc. (NYSE: PATH), a global leader in business orchestration and automation, today announced UiPath Maestro™ Flow, a developer-first orchestration canvas combining the speed of modern, AI-native development with enterprise-grade durability and governance. Using Maestro Flow, builders can use supported coding agents to design, run, observe, and govern an end-to-end process as a single artifact, from prototype to production.
With the popularity of coding agents, enterprise builders can build AI agents quickly, but struggle to implement and run them as real business processes across systems. Without a critical layer of orchestration, process logic becomes fragmented, difficult to govern, and costly to maintain—prototypes cannot ship, work stalls while waiting on review, automations are not tracked, and the cost of experimentation itself becomes a brake on progress.
Maestro Flow closes that gap. Builders can use the coding agents they already rely on—including Claude Code, Cursor, GitHub Copilot, and Codex—to design, run, observe, and govern complete business processes as a single artifact, all from their native development environment, such as VS Code or UiPath Studio. It is a fast, code-first build experience directly on an enterprise-grade orchestration engine, so the version prototyped is the version that ships into production, without rebuilding or re-platforming.
Maestro Flow enables teams to build at prototype speed and run with production durability. Teams keep the code-first workflow they already use, while enterprises gain the execution, observability, and governance needed for production. Coordinating AI agents, robots, APIs, documents, and people within one flow, Maestro Flow runs on the same Maestro orchestration engine enterprises already trust.
“Enterprises don't have an agent problem; they have an orchestration problem,” said Raghu Malpani, Chief Product and Technology Officer, UiPath. “With coding agents, it’s never been easier to build an agent. But running a real business process, spanning agents, robots, systems, and people—and being able to prove what happened at every step—needs an orchestration layer that ties these together in a real business environment. Maestro Flow is that missing layer, and it runs on the durable, governed orchestration foundation in the UiPath Platform that our customers already trust.”
Developers can get started today with UiPath Maestro Flow by clicking the “Try Now” button at www.uipath.com/product/maestro/flow. For those developers interested in trying out UiPath Maestro, UiPath is offering UiPath Maestro Lite, a lightweight option for processes that do not require extensive management, matching operational depth with the cost and criticality of the work.
About UiPath
UiPath (NYSE: PATH) is a leader in business orchestration and automation, trusted by organizations worldwide to transform enterprise complexity into intelligent, secure operations where AI agents reason, robots act, and people lead. Built for the modern enterprise and the world's most regulated industries, UiPath integrates automation, orchestration, AI, and testing into governed, scalable workflows—unlocking innovation at the speed of business while delivering the controls and compliance enterprise leaders demand. Visit www.uipath.com for more information.
In the latest trading session, UiPath (PATH - Free Report) closed at $10.70, marking a -11.13% move from the previous day. The stock fell short of the S&P 500, which registered a loss of 0.14% for the day. On the other hand, the Dow registered a loss of 0.01%, and the technology-centric Nasdaq decreased by 0.57%.
Prior to today's trading, shares of the enterprise automation software developer had gained 18.5% outpaced the Computer and Technology sector's loss of 4.82% and the S&P 500's gain of 0.25%.
The upcoming earnings release of UiPath will be of great interest to investors. The company's earnings per share (EPS) are projected to be $0.15, reflecting no change from the same quarter last year. Meanwhile, our latest consensus estimate is calling for revenue of $397.59 million, up 9.91% from the prior-year quarter.
Looking at the full year, the Zacks Consensus Estimates suggest analysts are expecting earnings of $0.8 per share and revenue of $1.78 billion. These totals would mark changes of +11.11% and +10.4%, respectively, from last year.
It's also important for investors to be aware of any recent modifications to analyst estimates for UiPath. These latest adjustments often mirror the shifting dynamics of short-term business patterns. As such, positive estimate revisions reflect analyst optimism about the business and profitability.
Research indicates that these estimate revisions are directly correlated with near-term share price momentum. To capitalize on this, we've crafted the Zacks Rank, a unique model that incorporates these estimate changes and offers a practical rating system.
Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. Within the past 30 days, our consensus EPS projection remained stagnant. UiPath is holding a Zacks Rank of #2 (Buy) right now.
Digging into valuation, UiPath currently has a Forward P/E ratio of 15.05. This represents a discount compared to its industry average Forward P/E of 19.55.
We can additionally observe that PATH currently boasts a PEG ratio of 0.72. The PEG ratio is akin to the commonly utilized P/E ratio, but this measure also incorporates the company's anticipated earnings growth rate. The Internet - Software industry had an average PEG ratio of 1.06 as trading concluded yesterday.
The Internet - Software industry is part of the Computer and Technology sector. With its current Zacks Industry Rank of 104, this industry ranks in the top 43% of all industries, numbering over 250.
The Zacks Industry Rank assesses the strength of our separate industry groups by calculating the average Zacks Rank of the individual stocks contained within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Make sure to utilize Zacks.com to follow all of these stock-moving metrics, and more, in the coming trading sessions.
Akcie UiPath za posledních šest měsíců klesly o 27 %, ale firma uvádí růst zákazníků s ARR nad 100 tisíc USD na 2 624 a nad 1 milion USD na 374. Zároveň se obchoduje na 13,82násobku forwardového zisku, pod průměrem odvětví.
Key Takeaways PATH is seeing agentic AI move into production while expanding workflow capabilities with Maestro Case.UiPath increased its customers with over $100K ARR to 2,624 and $1M ARR customers to 374.PATH trades at 13.82X forward earnings, below the industry average despite improving fundamentals. UiPath (PATH - Free Report) has experienced a sharp share price correction over the past six months, declining 27% compared with the industry’s 2% decline.
While concerns over AI competition and cautious enterprise spending have weighed on the stock, the company continues to strengthen its financial performance, expand its automation platform and deepen customer adoption. With a more reasonable valuation and growing traction in agentic AI, UiPath appears well-positioned to benefit from the next phase of enterprise automation.
Image Source: Zacks Investment Research
PATH’s Agentic AI Adoption Continues to AccelerateOne of the most encouraging developments for UiPath is the increasing adoption of its agentic AI platform. Roughly one year after making its agentic products generally available, the company is seeing customers move beyond pilot programs into full production deployments.
This transition is significant because production deployments typically indicate that customers are realizing measurable business value and integrating AI capabilities into mission-critical workflows rather than simply experimenting with new technology.
UiPath's role extends beyond simply providing AI agents. Its platform serves as an orchestration layer that coordinates workflows, automates execution and integrates AI-generated outputs directly into enterprise operations. As organizations increasingly deploy AI agents, this orchestration capability becomes increasingly valuable.
The recent introduction of UiPath for Coding Agents further strengthens the company's AI strategy by helping customers accelerate deployments and achieve faster time to value, potentially driving broader platform adoption across enterprise customers.
Maestro Case Broadens PATH’s Enterprise PlatformUiPath recently expanded its automation portfolio with the launch of Maestro Case, a capability designed to help enterprises manage complex, long-running workflows involving multiple participants, business systems and AI agents.
Many organizations still rely on fragmented processes involving emails, spreadsheets, and disconnected software to manage customer requests, approvals, and investigations. Maestro Case addresses these inefficiencies by treating every business case as an evolving workflow while combining automation with human oversight.
The launch appears to expand UiPath's competitive positioning against ServiceNow (NOW - Free Report) and Pegasystems (PEGA - Free Report) . While ServiceNow has built a strong franchise in enterprise workflow management and Pegasystems has long specialized in case management and business process automation, UiPath aims to differentiate itself by integrating robotic process automation, workflow orchestration, and agentic AI within a unified platform. As enterprises increasingly seek AI-enabled workflow solutions, PATH's broader automation capabilities could provide a meaningful competitive advantage over Pegasystems and ServiceNow.
Large Customer Growth Supports Long-Term OutlookUiPath continues to demonstrate strong enterprise adoption, particularly among its largest customers.
Customers generating more than $100,000 in annual recurring revenue increased from 2,365 to 2,624 over the past year, reflecting broader platform adoption and continued expansion within existing enterprise accounts.
Even more encouraging, customers contributing more than $1 million in ARR increased from 316 to 374. These larger customers typically represent deeper deployments, stronger retention and greater long-term expansion opportunities.
The company's expanding enterprise presence also strengthens its competitive position relative to Pegasystems, ServiceNow and Salesforce. While Salesforce continues to invest aggressively in enterprise AI and workflow automation, UiPath is carving out a differentiated position by combining robotic process automation, AI orchestration and workflow management into a single platform. Likewise, Salesforce's broader AI initiatives further validate the growing enterprise demand that UiPath is targeting.
Healthy Growth Projections StrengthenUiPath's long-term growth outlook remains healthy, supported by steady expansion in both earnings and revenues. The Zacks Consensus Estimate projects earnings growth of 10.4% in fiscal 2027, followed by an additional 8.2% increase in fiscal 2028, indicating sustained profitability despite a maturing business. Revenue growth is also expected to remain robust, with sales forecast to rise 11.1% in fiscal 2027 and 12.7% in fiscal 2028. The acceleration in top-line growth during fiscal 2028 suggests continued demand for UiPath's AI-powered automation platform, while consistent earnings expansion reflects improving operating leverage and disciplined execution.
Image Source: Zacks Investment Research
Although risks such as enterprise IT spending uncertainty and intensifying competition remain, much of this caution now appears reflected in the current valuation, creating a more favorable risk-reward profile for patient investors.
Attractive Valuation Creates a Better Entry PointThe recent pullback has compressed its valuation to a forward price-to-earnings multiple of 13.82X, well below the industry average of 28.28X.
Image Source: Zacks Investment Research
The lower valuation comes despite improving business fundamentals. Annualized recurring revenue (ARR) continues to expand steadily, operating margins have improved and UiPath recently reported its first-ever first-quarter GAAP profit. Management also raised its full-year guidance, signaling confidence in customer demand and the company's ability to monetize its expanding AI-powered automation portfolio.
PATH is a Buy NowUiPath's recent share price weakness appears disconnected from its improving operating performance. The company is expanding profitability, growing recurring revenue, strengthening relationships with large enterprise customers, and successfully extending its platform into workflow orchestration and agentic AI.
Although competitive pressures and macroeconomic uncertainty remain important risks, UiPath's discounted valuation, expanding AI capabilities, and growing enterprise adoption suggest the long-term investment thesis remains intact. If management continues executing on its AI roadmap while sustaining profitable growth, the current pullback could prove to be an attractive buying opportunity for long-term investors.
PATH stock currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Key Takeaways UiPath shares have fallen 34% in six months, while trading below the industry's forward earnings multiple.PATH reported its first-quarter GAAP profit and raised its full-year outlook on stronger demand.UiPath is positioning its platform to combine RPA, AI agents and workflows for enterprise automation. UiPath’s (PATH - Free Report) recent share price pullback has made its valuation more compelling, particularly for long-term investors. Despite improving financial performance and stronger demand for its automation platform, the stock trades at a more reasonable forward earnings multiple than it did during its earlier rally. This disconnect suggests that much of the market’s caution surrounding AI-related competition and enterprise spending has already been reflected in the share price.
The stock has declined 34% over the past six months compared with the industry’s 6.5% decline.
< Image Source: Zacks Investment Research
PATH trades at a forward price-to-earnings ratio of 13.53X, which is well below the industry’s average of 27.31X.
Image Source: Zacks Investment Research
The company continues to strengthen its fundamentals. Annualized recurring revenue (ARR) has maintained steady growth, operating margins have expanded, and UiPath recently reported its first-ever first-quarter GAAP profit. Management also raised its full-year outlook, reflecting confidence in customer demand and the company's ability to monetize its AI-powered automation offerings.
As enterprises increasingly adopt agentic AI, UiPath is positioning itself as an orchestration layer that combines robotic process automation (RPA), AI agents, and workflow management. This strategy could help customers automate complex business processes while optimizing AI token usage, creating a differentiated value proposition.
Although risks remain, including competitive pressure and slower enterprise IT spending, the current valuation appears to offer a favorable risk-reward balance. If UiPath continues to execute on its AI roadmap and sustain profitable growth, today's discounted valuation could provide meaningful upside potential for patient, long-term investors.
Peer Comparison
Microsoft (MSFT - Free Report) and ServiceNow (NOW - Free Report) remain formidable rivals, but their financial strategies differ from UiPath’s. Microsoft, while a giant with unparalleled scale, must spread capital across diverse segments such as cloud, gaming and productivity software, somewhat diluting its focus on automation. ServiceNow continues to gain traction in enterprise workflow automation but remains heavily invested in sustaining growth momentum, balancing expansion with cost pressures.
Compared to these players, UiPath’s debt-free balance sheet allows it to dedicate resources squarely to automation. Microsoft has the advantage of size, and ServiceNow has enterprise reach, but UiPath’s singular financial flexibility gives it agility neither can fully replicate.
PATH stock currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
UiPath spustil Maestro Case pro řízení složitých workflow s lidmi, systémy i AI. Tím se více přibližuje konkurenci ServiceNow a Pegasystems v oblasti workflow a case managementu.
Key Takeaways PATH introduced Maestro Case to manage long-running, exception-heavy workflows across people, systems and AI.UiPath is targeting fragmented processes like approvals, investigations and service issues.PATH's launch positions it more directly against ServiceNow and Pegasystems in workflow and case management. UiPath (PATH - Free Report) is expanding its automation portfolio with Maestro Case, a new capability designed to help enterprises manage more complex workflows that don’t move in a straight line. The launch reflects a broader shift in enterprise software, where businesses increasingly need tools that can handle not just repetitive tasks, but also long-running, exception-heavy processes involving people, systems and AI.
The opportunity here is meaningful because many organizations still manage customer requests, investigations, approvals, and service issues through fragmented tools such as emails, spreadsheets and point solutions. That creates delays, weak visibility, and inconsistent outcomes. Maestro Case is intended to address that problem by allowing businesses to treat each case as an evolving workflow, carrying its data, participants and execution context from one stage to another while combining automation with human oversight when needed.
The launch also places UiPath more directly alongside peers such as ServiceNow (NOW - Free Report) and Pegasystems (PEGA - Free Report) , both of which have built strong positions in workflow and case-oriented enterprise software. ServiceNow has long focused on digital workflows across IT and business functions, while Pegasystems has built its reputation around process automation and case management for large enterprises. By pushing deeper into this category, UiPath is signaling that it wants to compete more aggressively with ServiceNow in workflow orchestration and with Pegasystems in complex case handling. At the same time, PATH’s AI-led positioning could help it differentiate its offering from ServiceNow and Pegasystems if customers increasingly prioritize agent-driven automation layered on top of traditional workflow tools.
Overall, Maestro Case looks like a strategic extension of UiPath’s platform rather than a routine product add-on, reinforcing its effort to become a broader enterprise orchestration player.
PATH’s Price Performance, Valuation and Estimates
The stock has declined 39% year to date compared with the industry’s 18% loss.
Image Source: Zacks Investment Research
From a valuation standpoint, PATH trades at a forward price-to-earnings ratio of 11.91, which is well below the industry average of 24.48. It carries a Value Score of C.
The Zacks Consensus Estimate for PATH’s fiscal 2027 earnings has been on the rise over the past 30 days.
Image Source: Zacks Investment Research
PATH currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
